Loading your page…
Each register with its number of medicines and a few of them.
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
AEMPS · 27 medicines
FDA · 24 medicines
CBG-MEB · 22 medicines
Health Canada · 18 medicines
MS · 10 medicines · Historical list
SFDA · 10 medicines · Historical list
PHARMAC · 4 medicines
HALMED · 1 medicine
Every register, a page at a time. Strengths and packs are on each medicine’s page.
24 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Desogestrel; EthinylCombination | United States | 0.125MG/0.025MG, 0.15MG/0.025MG | Tablet | Marketed | Duramed Pharms Barr |
| Desogestrel and Ethinyl EstradiolCombination | United States | 0.15MG,N/A; 0.02MG,0.01MG, 0.15MG; 0.03MG, 0.1MG,0.125MG,0.15MG; 0.025MG,0.025MG,0.025MG | tablet | Marketed | DR Reddys Labs SA |
| Desogestrel; Ethinyl EstradiolCombination | United States | 0.125MG/0.025MG, 0.15MG/0.025MG | tablet | Marketed | DR Reddys Labs SA |
| Desogestrel and Ethinyl EstradiolCombination | United States | 0.15MG; 0.03MG | tablet | Not marketed | Duramed Pharms Barr |
| DesogenCombination | United States | 0.15MG; 0.03MG | tablet | Not marketed | Organon USA INC |
| DesogenCombination | United States | 0.15MG; 0.03MG | tablet | Not marketed | Organon USA INC |
| VioreleCombination | United States | 0.15MG,N/A; 0.02MG,0.01MG | tablet | Marketed | Glenmark Pharms LTD |
| EnskyceCombination | United States | 0.15MG; 0.03MG | tablet | Marketed | Lupin LTD |
| IsibloomCombination | United States | 0.15MG; 0.03MG | tablet | Marketed | Xiromed |
| KalligaCombination | United States | 0.15MG; 0.03MG | tablet | Marketed | Aurobindo Pharma |
| KarivaCombination | United States | 0.15MG,N/A; 0.02MG,0.01MG | tablet | Marketed | Barr |
| SimliyaCombination | United States | 0.15MG,N/A; 0.02MG,0.01MG | tablet | Marketed | Aurobindo Pharma |
| VelivetCombination | United States | 0.1MG,0.125MG,0.15MG; 0.025MG,0.025MG,0.025MG | tablet | Marketed | Duramed Pharms Barr |
| VolneaCombination | United States | 0.15MG,N/A; 0.02MG,0.01MG | tablet | Marketed | Xiromed |
| PimtreaCombination | United States | 0.15MG,N/A; 0.02MG,0.01MG | tablet | Marketed | Novast Labs |
| AveriCombination | United States | 0.15MG; 0.03MG | tablet | Marketed | Avion Pharms |
| AveriCombination | United States | 0.15MG; 0.03MG | tablet | Marketed | Avion Pharms |
| BekyreeCombination | United States | 0.15MG,N/A; 0.02MG,0.01MG | tablet | Marketed | Lupin |
| CyclessaCombination | United States | 0.1MG,0.125MG,0.15MG; 0.025MG,0.025MG,0.025MG | tablet | Marketed | Aspen Global INC |
| KimidessCombination | United States | 0.15MG,N/A; 0.02MG,0.01MG | tablet | Not marketed | PH Health |
| EmoquetteCombination | United States | 0.15MG; 0.03MG | tablet | Not marketed | PH Health |
| MircetteCombination | United States | 0.15MG,N/A; 0.02MG,0.01MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet | Not marketed | Teva Branded Pharm |
| Ortho-CeptCombination | United States | 0.15MG; 0.03MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet | Not marketed | Janssen Pharms |
| Ortho-CeptCombination | United States | 0.15MG; 0.03MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet | Not marketed | Janssen Pharms |
The same brand on several registers.
The companies holding its medicines, the most first.
Substances it shares a medicine with.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, ALIMS, Anvisa, CBG-MEB, FDA, HALMED, Health Canada, HSA, MS, PHARMAC and SFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
